Authors: DURELLI L BONGIOANNI MR FERRERO B OGGERO A MARZANO A RIZZETTO M

Citation: L. Durelli et al., INTERFERON TREATMENT FOR MULTIPLE-SCLEROSIS - AUTOIMMUNE COMPLICATIONS MAY BE LETHAL, Neurology, 50(2), 1998, pp. 570-571

Authors: FERRERO B BONGIOANNI MR MOIA MC OGGERO A GEUNA M PAGNI R DURELLI L

Citation: B. Ferrero et al., CORTICOSTEROID-INDUCED WORSENING OF MYASTHENIA-GRAVIS (MG) CORRELATESWITH INCREASED IN-VIVO ANTIACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY (AB) LEVEL AND IN-VITRO IMMUNOGLOBULIN (IG) G-RELEASE, Neurology, 48(3), 1997, pp. 1006-1006

Authors: OGGERO A BONGIOANNI MR MARZANO A AIMO G GENTILE E RIZZETTO M DURELLI L

Citation: A. Oggero et al., THYROID AND LIVER AUTOIMMUNITY DURING INTERFERON (IFN) TREATMENT FOR MULTIPLE-SCLEROSIS (MS) MAY BE AT TIMES LETHAL, Neurology, 48(3), 1997, pp. 4075-4075

Authors: BONGIOANNI MR DURELLI L FERRERO B IMPERIALE D OGGERO A VERDUN E AIMO G PAGNI R GEUNA M BERGAMASCO B

Citation: Mr. Bongioanni et al., SYSTEMIC HIGH-DOSE RECOMBINANT-ALPHA-2A-INTERFERON THERAPY MODULATES LYMPHOKINE PRODUCTION IN MULTIPLE-SCLEROSIS, Journal of the neurological sciences, 143(1-2), 1996, pp. 91-99